基本信息
浏览量:1
职业迁徙
个人简介
He is also interested to find new applications of existing cGMP-elevating drugs, such as Viagra, to treat important human diseases. There he obtained a strong background in transgenic mouse methods and contributed to the development of so-called Tamoxifen-dependent Cre recombinases including CreERT2, which is now widely used for the generation of inducible knockout mice as well as for genetic cell fate mapping in mice. In 2002 the Feil group has published the first cardiomyocyte-specific cGK knockout mouse model and by now has generated a “mouse zoo” with several inducible, tissue-specific and rescue mouse mutants. The in vivo phenotypes of these mouse models combined with analyses at the cellular and molecular level demonstrated that the cGKs are major players of cGMP signalling. Surprisingly, the cGMP-cGK axis turned out to promote the growth of multiple cell types in the context of cardiovascular and neuronal disorders as well as cancer. More recently, the Feil lab has established new Cre/lox-switchable mouse models for real-time imaging of cGMP and, more broadly, tracking the behaviour of any specific cell type in vivo. Using these new technologies, they could show that atherosclerotic plaques contain previously unknown macrophage-like cells that are derived by clonal growth and transdifferentiation of vascular smooth muscle cells. Dr. Feil’s work is supported by the Deutsche Forschungsgemeinschaft (DFG) and others, and it receives considerable attention as reflected by a survey that ranked him on position 14 among the most-cited pharmacologists in Germany, Austria and Switzerland (Laborjournal 7-8/2009, corrected online version). Since 2013, Dr. Feil is speaker of the DFG-funded research centre “cGMP signalling in cell growth and survival” (FOR 2060). Since 2019, he is speaker of the DFG research training group "cGMP: from bedside to bench" (GRK 2381).
研究兴趣
论文共 347 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Anne-Katrin Rohlfing,Marcel Kremser, David Schaale, Valerie Dicenta-Baunach, Zoi Laspa,Xiaoqing Fu,Laimdota Zizmare,Manuel Sigle,Tobias Harm,Patrick Muenzer, Andreas Pelzer,Oliver Borst,
THROMBOSIS RESEARCH (2024): 63-74
Aylin Balmes,Johanna G. Rodriguez,Jan Seifert, Daniel Pinto-Quintero,Akif A. Khawaja,Marta Boffito,Maike Frye,Andreas Friebe,Michael Emerson,Francesca Seta,Robert Feil,Susanne Feil,
Peter Seizer, Saskia N I von Ungern-Sternberg, Verena Haug,Valerie Dicenta, Annabelle Rosa,Elke Butt, Moritz Nöthel,Anne-Katrin Rohlfing,Manuel Sigle,Peter P Nawroth,Claudia Nussbaum,Markus Sperandio,
Cardiovascular researchno. 4 (2024): 385-402
bioRxiv (Cold Spring Harbor Laboratory)no. 1 (2024): 2313359-2313359
Johanna G. Rodriguez,Aylin Balmes,Jan Seifert, Daniel Pinto,Andreas Friebe,Francesca Seta,Robert Feil, Sussanne Feil,Tilman E. Schaeffer
JOURNAL OF TRANSLATIONAL MEDICINEno. SUPPL 1 (2023)
引用0浏览0引用
0
0
Atherosclerosis (2023): S8-S8
引用0浏览0引用
0
0
JOURNAL OF TRANSLATIONAL MEDICINEno. SUPPL 1 (2023)
引用0浏览0引用
0
0
Moritz Lehners, Maria T. K. Zaldivia,Julia Adler,Robert Lukowski,Hannes Schmidt,Susanne Feil,Robert Feil
JOURNAL OF TRANSLATIONAL MEDICINEno. SUPPL 1 (2023)
引用0浏览0引用
0
0
CIRCULATION RESEARCHno. 6 (2023): 747-750
JOURNAL OF TRANSLATIONAL MEDICINEno. SUPPL 1 (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn